📌20 years later: unravelling the genomic success of New Zealand’s home-grown AK3 community-associated methicillin-resistant Staphylococcus aureus
How NZ’s #antibiotic habits fuelled a superbug
Once local, now global
Out now & #OpenAccess | @MicrobioSoc
https://t.co/VrlC4Pl1IP
🚨Thrilled to share our recent preprint: "Interrogating the Escherichia coli epitranscriptome via CRISPR interference and Nanopore native RNA sequencing" 🦠https://t.co/voJPJdKNeQ
This work was possible through collaboration across Aotearoa. From diagnostic labs & surveillance programmes to genomics, AMR & science teams at @PHFScience, alongside international collaborators.
Shout out to Alexander Sundermann (@PittTweet) for linking NZ & USA collaborators
Hospital infections are sometimes assumed to spread between patients
But what if they’re not?
📌Decentralized nanopore genomics reveals diverse Klebsiella pneumoniae and no evidence of patient–patient transmission in a New Zealand hospital @MicrobioSoc
https://t.co/P9WYGATho7
We embedded @nanopore sequencing directly into a frontline diagnostic lab.
We sequenced routine Klebsiella pneumoniae isolates collected at Wellington Regional Hospital.
Surprisingly, most infections were genomically unrelated with no evidence of patient-to-patient transmission
New post-doctoral research position available in my Phage-host interactions (Phi) laboratory at the @otago in the Department of Microbiology and Immunology. The project is focused on defences against jumbo phages. Please share and if interested apply using the link below.
Reviewers can’t assess data quality, mixtures, coverage, or assembly robustness without access to the sequence data.
Peer review without data isn’t #PeerReview.
Journals should enforce data availability before review, not after.
#OpenScience#Genomics
It’s 2026.
If you submit a #Genomics paper without making the underlying sequence data publicly available, reproducibility is...
👉I M P O S S I B L E👈
#OpenScience data isn’t optional. It’s foundational to #PublicHealth, benchmarking, & scientific credibility
From a neonatal ICU in Wellington to clinics in Africa & Europe: a new @ghn_news feature shows how onsite @nanopore genome sequencing is reshaping #InfectionPrevention… helping to deliver answers in hours, not weeks, & turning #Genomic into real-world action
#PublicHealth
Faster, cheaper technologies that can do onsite genome sequencing are improving pathogen surveillance in lower-income settings. https://t.co/4FkhHwpsG4
🧵BIG PROBLEMS can hide in small #Plasmids
📌Integration of blaOXA-48 into a Col156 plasmid drove a carbapenem-resistant Escherichia coli ST131 outbreak in New Zealand: Global genomic evidence for the gene’s multilayered dissemination
https://t.co/85ODuNzDjz
#ScienceTwitter
What didn’t work (at first)
Standard bacterial whole-genome sequencing told us about related cases, but not how the resistance was moving
It took complete genomes to see that this plasmid is global, stable, & quietly successful
#ScientificProcess#Genomics#AMR#LessonsLearned